[VRTX] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
01-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -82.67%
YoY- 27.76%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 2,097,500 1,724,305 1,515,107 858,435 640,799 714,718 398,080 31.89%
PBT 954,800 820,960 657,534 320,165 214,642 253,533 -30,617 -
Tax 192,700 167,822 54,781 51,534 -12,659 3,985 5,485 80.92%
NP 762,100 653,138 602,753 268,631 210,263 247,756 -41,631 -
Tax Rate -20.18% -20.44% -8.33% -16.10% 5.90% -1.57% - -
Total Cost 1,335,400 1,071,167 912,354 589,804 430,536 466,962 439,711 20.32%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 36.33 37.88 39.78 31.29 32.81 34.66 -10.46 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS 2.99 2.52 2.32 1.05 0.83 1.01 -0.17 -
EPS Diluted 2.96 2.49 2.29 1.03 0.81 0.99 -0.17 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.